GenomeMe

GenomeMe Inc. is a biotech company that specializes in developing and manufacturing mouse and rabbit immunohistochemistry (IHC) monoclonal antibodies for clinical diagnostic use. The company's core business is to produce high-quality IHC antibodies, with a goal of developing over 260 clinical IHC antibodies in-house. They offer these antibodies at wholesale prices to distributors, OEM partners, and end-users, and also provide custom development services for special markers. GenomeMe's products are certified for diagnostic use, conforming to international standards such as ISO 13485:2016 and CE IVD, and are used in various applications including cancer research and diagnosis.

GenomeMe is at the forefront of a movement to make Precision Medicine a new paradigm for healthcare. Our genetic tests and diagnostic kits enable physicians to peer deep into the unique origins of health and disease within each of their patients, radically customizing the healthcare they can deliver.

Our newly renovated facility is CAN/CSA ISO 13485:2003 and EN ISO 13485:2012 certified. We are currently in the process of acquiring certification by CAP (College of American Pathologists), and DAP (Diagnostic Accreditation Program) to bring the highest standards of safety and quality to every product and service we offer no matter where in the world you are.

Molecular Pathology
GeneAb recombinant monoclonal antibodies are engineered to deliver consistent, specific, and sensitive stains—so you can make a confident diagnosis every time.

Molecular Diagnostics
GeneNav Diagnostic Kits
See the complete picture of your patient’s health with our highly accessible line of medical diagnostic kits.

Genetic Testing
Genetic Panels
Learn about your patient’s unique genetic profile so you can deliver care uniquely tailored for them.